One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy

PURPOSE: To compare the 1-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy (RF-PDT) to intravitreal ranibizumab (IVR) alone for eyes with polypoidal choroidal vasculopathy (PCV). METHODS: We reviewed the medical records from 47 consecutive patients with PCV...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakurai, Madoka, Baba, Takayuki, Kitahashi, Masayasu, Yokouchi, Hirotaka, Kubota-Taniai, Mariko, Bikbova, Guzel, Oshitari, Toshiyuki, Yamamoto, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913546/
https://www.ncbi.nlm.nih.gov/pubmed/24511222
http://dx.doi.org/10.2147/OPTH.S54578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913546/
https://www.ncbi.nlm.nih.gov/pubmed/24511222
http://dx.doi.org/10.2147/OPTH.S54578

Ejemplares similares